Anti-inflammatory Mechanism of Seaweeds in Murine Macrophage

  • Pan, Cheol-Ho (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Branch) ;
  • Kim, Eun-Sun (Department of Science Education (Biology), College of Education, Chungbuk National University) ;
  • Um, Byung-Hun (Natural Products Research Center, Korea Institute of Science and Technology Gangneung Branch) ;
  • Lee, Jae-Kwon (Department of Science Education (Biology), College of Education, Chungbuk National University)
  • 발행 : 2009.06.30

초록

The effect of 4 seaweed extracts (Desmarestia viridis, Dictyopteris divaricata, Scytosiphon lomentaria, and Ishige okamurae) on pro-inflammatory mediators as well as nuclear factor $(NF)-{\kappa}B$ in the stimulated Raw 264.7 cells was investigated. They reduced iNOS and interlukin $(IL)-1{\beta}$ expressions at transcription level. Of those, 3 extracts (D. divaricata, I. okamurae, and S. lomentaria) inhibited the COX-2 expression at translation level. $I{\kappa}B-{\alpha}$ degradation was inhibited by D. divaricata and S. lomentaria extracts. Therefore, we concluded that the extracts from D. divaricata and S. lomentaria could inhibit the activation of murine macrophage through the blocking of $NF-{\kappa}B$ activation.

키워드

참고문헌

  1. Ito K, Hori K. Seaweed: Chemical composition and potential food uses. Food Rev. Int. 5: 101-144 (1989) https://doi.org/10.1080/87559128909540845
  2. Darcy-Vrillon B. Nutritional aspects of the developing use of marine macroalgae for the human food industry. Int. J. Food Sci. Nutr. 44: S23-S35 (1993)
  3. MacArtain P, Gill CI, Brooks M, Campbell R, Rowland IR. Nutritional value of edible seaweeds. Nutr. Rev. 65: 535-543 (2007) https://doi.org/10.1111/j.1753-4887.2007.tb00278.x
  4. Takamatsu S, Hodges TW, Rajbhandari I, Gerwick WH, Hamann MT, Nagle DG. Marine natural products as novel antioxidant prototypes. J. Nat. Prod. 66: 605-608 (2003) https://doi.org/10.1021/np0204038
  5. Iwai K. Antidiabetic and antioxidant effects of polyphenols in brown alga Ecklonia stolonifera in genetically diabetic KK-A$^{y}$ mice. Plant Food Hum. Nutr. 63: 163-169 (2008) https://doi.org/10.1007/s11130-008-0098-4
  6. Ushakova NA, Preobrazhenskaya ME, D'Incecco A, Piccoli A, Totani L, Tinari N, Morozevich GE, Berman AE, Bilan MI, Usov AI, Ustyuzhanina NE, Grachev AA, Sanderson CJ, Kelly M, Rabinovich GA, Iacobelli S, Nifantiev NE. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of 9 different fucoidans from brown seaweeds. Glycobiology 17: 541-552 (2007) https://doi.org/10.1093/glycob/cwm014
  7. Khan MN, Cho JY, Lee MC, Kang JY, Park NG, Fujii H, Hong YK. Isolation of two anti-inflammatory and one pro-inflammatory polyunsaturated fatty acids from the brown seaweed Undaria pinnatifida. J. Agr. Food Chem. 55: 6984-6988 (2007) https://doi.org/10.1021/jf071791s
  8. Kang JY, Khan MN, Park NH, Cho JY, Lee MC, Fujii H, Hong YK. Antipyretic, analgesic, and anti-inflammatory activities of the seaweed Sargassum fulvellum and Sargassum thunbergii in mice. J. Ethnopharmacol. 116: 187-190 (2008) https://doi.org/10.1016/j.jep.2007.10.032
  9. Medeiros VP, Queiroz KC, Cardoso ML, Monteiro GR, Oliveira FW, Chavante SF, Guimaraes LA, Rocha HA, Leite EL. Sulfated galactofucan from Lobophora variegata: Anticoagulant and antiinflammatory properties. Biochemistry -Moscow+ 73: 1018-1024 (2008) https://doi.org/10.1134/S0006297908090095
  10. Kim MS, Kim JY, Choi WH, Lee SS. Effects of seaweed supplementation on blood glucose concentration, lipid profile, and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Nutr. Rep. Rev. 2: 62-67 (2008) https://doi.org/10.4162/nrp.2008.2.2.62
  11. Wang H, Ooi EV, Ang PO. Antiviral activities of extracts from Hong Kong seaweeds. J. Zhejiang Univ. Sci. B. 9: 969-976 (2008) https://doi.org/10.1631/jzus.B0820154
  12. Lee SB, Lee JY, Song DG, Pan CH, Nho CW, Kim MC, Lee EH, Jung SH, Kim HS, Kim YS, Um BH. Cancer chemopreventive effects of Korean seaweed extracts. Food Sci. Biotechnol. 17: 613-622 (2008)
  13. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126: 131-138 (1982) https://doi.org/10.1016/0003-2697(82)90118-X
  14. Wang HQ, Smart RC. Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2, and TNFalpha expression but not tumor promotion. J. Cell Sci. 112: 3497-3506 (1999)
  15. Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38: 151-160 (1995) https://doi.org/10.1002/art.1780380202
  16. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14: 397-440 (1996) https://doi.org/10.1146/annurev.immunol.14.1.397
  17. Brennan FM, Maini RN, Feldmann M. Role of pro-inflammatory cytokines in rheumatoid arthritis. Springer Semin. Immun. 20: 133-147 (1998) https://doi.org/10.1007/BF00832003
  18. Hewett JA, Roth RA. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol. Rev. 45: 382-411 (1993)
  19. Kubes P, McCafferty DM. Nitric oxide and intestinal inflammation. Am. J. Med. 109: 150-158 (2000) https://doi.org/10.1016/S0002-9343(00)00480-0
  20. Donadelli R, Abbate M, Zanchi C, Corna D, Tomasoni S, Benigni A, Remuzzi G, Zoja C. Protein traffic activates NF-$\kappa$B gene signaling and promotes MCP-1-dependent interstitial inflammation. Am. J. Kidney Dis. 36: 1226-1241 (2000) https://doi.org/10.1053/ajkd.2000.19838
  21. Ray A, Siegel MD, Prefontaine KE, Ray P. Anti-inflammation: Direct physical association and functional antagonism between transcription factor NF-$\kappa$B and the glucocorticoid receptor. Chest 107: 139S (1995) https://doi.org/10.1378/chest.107.3_Supplement.139S
  22. Giuliani C, Napolitano G, Bucci I, Montani V, Monaco F. NF-$\kappa$B transcription factor: Role in the pathogenesis of inflammatory, autoimmune, and neoplastic diseases and therapy implications. Clin. Ther. 152: 249-253 (2001)
  23. Notarbartolo M, Poma P, Perri D, Dusonchet L, Cervello M, D'Alessandro N. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-$\kappa$B activation levels and in IAP gene expression. Cancer Lett. 224: 53-65 (2005) https://doi.org/10.1016/j.canlet.2004.10.051
  24. Karin M. The beginning of the end: IkappaB kinase (IKK) and NFkappaB activation. J. Biol. Chem. 274: 27339-27342 (1999) https://doi.org/10.1074/jbc.274.39.27339
  25. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147 (1996)
  26. Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol. Today 12: 404-410 (1991) https://doi.org/10.1016/0167-5699(91)90142-G
  27. Reznikov LL, Kim SH, Westcott JY, Frishman J, Fantuzzi G, Novick D, Rubinstein M, Dinarello CA. IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma. P. Natl. Acad. Sci. USA 97: 2174-2179 (2000) https://doi.org/10.1073/pnas.040582597
  28. Ahsan S, Lacey M, Whitehead SA. Interactions between interleukin-1 beta, nitric oxide, and prostaglandin E2 in the rat ovary: Effects on steroidogenesis. Eur. J. Endocrinol. 137: 293-300 (1997) https://doi.org/10.1530/eje.0.1370293
  29. Ellman C, Corbett JA, Misko TP, McDaniel M, Beckerman KP. Nitric oxide mediates interleukin-1-induced cellular cytotoxicity in the rat ovary. A potential role for nitric oxide in the ovulatory process. J. Clin. Invest. 92: 3053-3056 (1993) https://doi.org/10.1172/JCI116930
  30. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA. Possible new role for NF-kappaB in the resolution of inflammation. Nat. Med. 7: 1291-1297 (2001) https://doi.org/10.1038/nm1201-1291
  31. Renard P, Raes M. The proinflammatory transcription factor NFkappaB: A potential target for novel therapeutical strategies. Cell. Biol. Toxicol. 15: 341-344 (1999) https://doi.org/10.1023/A:1007652414175
  32. Barnes PJ, Karin M. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. New Engl. J. Med. 336: 1066-1071 (1997) https://doi.org/10.1056/NEJM199704103361506
  33. Makarov SS. NF-kappaB as a therapeutic target in chronic inflammation: Recent advances. Mol. Med. Today 6: 441-448 (2000) https://doi.org/10.1016/S1357-4310(00)01814-1
  34. Zhang G, Ghosh S. Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J. Endotoxin Res. 6: 453-457 (2000)
  35. Takaoka A, Yanai H. Interferon signalling network in innate defence. Cell Microbiol. 8: 907-922 (2006) https://doi.org/10.1111/j.1462-5822.2006.00716.x